Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2022-02-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Eubiologics regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment period end date due to delays caused by COVID-19. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment updates, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Dividends, or Share Issues.
2022-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by an executive (Shin Young Hee) of Eubiologics, including the date of the transaction and the number of shares sold. This is a standard insider trading disclosure, which falls under the 'Director's Dealing' category.
2022-02-21 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Eubiologics regarding a significant change in revenue or profit structure (30% or more). This is a standard Korean regulatory disclosure (DART filing) for material financial changes. Since it provides the initial announcement of financial results (key highlights) rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2021
2022-02-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Eubiologics. It outlines the date, location, and specific agenda items (financial statement approval, director appointments, and compensation limits). This type of document is a standard proxy solicitation material provided to shareholders to inform them of upcoming meeting details and to request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2022-02-11 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Eubiologics) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) with UNICEF. This is a specific type of material event disclosure required by the Korea Exchange (KRX). Since it does not fit into categories like M&A, dividends, or share repurchases, and is a standard regulatory disclosure of a business contract, it falls under the 'Regulatory Filings' (RNS) category.
2022-02-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by BioNote, Inc. in U-BioLogics) and the purpose of holding (changing from general investment to management participation). This falls under the category of Major Shareholding Notification.
2022-02-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.